Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by BayStreetWildon Feb 07, 2023 2:38pm
125 Views
Post# 35272500

RE:RE:RE:I like it !

RE:RE:RE:I like it !

MM October 06, 2022

mercedesman wrote: Agreed Rev

IMO this fall will not be a repeat of last fall despite some recent BS(W) posts.

1) Enrollment ramp-up at hand (flu season back with a vengence in 2022 - see southern hemisphere coming to North, 17-25 Trial sites, ICU more clear after CV lull period, etc). 

2) Likely news on the Dialco side (this financing only deals with PMX).  I don't see back to back market financings.   I think there is someone out there that sees the next FDA approved machine on the horizon and wants to get in on the ground floor.  That should somewhat wake up the market on hidden value/ under priced assets.

3) Different buyers of this financing. Instead of a detached US institution looking to cash in on warrants, this is "strategic partners", insiders and larger shareholders (stronger hands)

4) Spectral has appreciated throughout the market malaise (from .16 to 40's and 50's)...so now there is  less need for tax loss selling.   Plus short term possibilities on Dialco would make it a dangerous short...so would ramped up enrollment (agreed we still need evidence first - but JK needs to regain his credibility)

MM



Revten wrote: Looks like we will be Buying More Shares at a Bargain Basment Price thanks to the Weak Hands who clearly are not seeing what Is Really Going On Here!
Wake Up People! This is not an If FDA Approval....It's just a matter Of When it is FDA Approved!
The insiders are only taking advantage of TIME! 
it's All About Timing....and we will all look back at .40 and say...WAS I ASLEEP??

This is a Much Better and more realistic type of Financing!
Clearly the Trial is going MUCH MUCH Better Than Expected and a Strategic Partner? Wake Up!

Still Very REVED Up and will be ONLY on the Buy Side until we are Trading 5 to 10 Million Shares A Day! That is when I will be able to Liquidate such a Large Position!



 

<< Previous
Bullboard Posts
Next >>